India’s global pharma status hinges on regulatory strengthening: Dr Chandrashekar Ranga: Nandita Vijayasimha, Bengaluru Tuesday, July 15, 2025, 08:00 Hrs [IST] Strengthening Ind ...

AI in Cancer Drug Discovery could prove paradigm shifting, but what challenges does it present? And how can they be avoided?

The U.S. Food and Drug Administration (FDA) announced a landmark decision on April 10, 2025, phasing out mandatory animal ...

In April 2025, the US Food and Drug Administration (FDA) published a roadmap for leveraging new approach methodologies (NAMs), including in silico approaches such as artificial intelligence (AI), to ...

While AI-driven approaches tout increased speed and lower costs, commercial interests compromise scientific collaboration.

SKNY Pharmaceuticals' drug candidate, SKNY-1, demonstrated up to 30% weight loss in an animal model, along with reduced cravings for high-calorie foods and nicotine.

Earlier, in January 2025, the FDA released a companion piece of draft guidance titled “Considerations for the Use of ...

AbCellera's AI-driven drug discovery model hasn't translated into meaningful growth. Click here to read an analysis of ABCL ...

See disclosure here or remove ads. The company is advancing Mira-55 toward an Investigational New Drug submission, with ongoing activities supporting future clinical development in inflammatory pain.

The U.S. Drug Enforcement Administration confirmed that Mira-55 is not classified as a controlled substance, facilitating its clinical development. The company is also advancing Mira-55 toward an ...